Cargando…
Effects of crystalloid, hyper-oncotic albumin, and iso-oncotic albumin on lung and kidney damage in experimental acute lung injury
BACKGROUND: Conflicting data have reported beneficial effects of crystalloids, hyper-oncotic albumin (20%ALB), and iso-oncotic albumin (5%ALB) in critically ill patients. Although hyper-oncotic albumin may minimize lung injury, recent studies have shown that human albumin may lead to kidney damage p...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6636113/ https://www.ncbi.nlm.nih.gov/pubmed/31311539 http://dx.doi.org/10.1186/s12931-019-1115-x |
_version_ | 1783436006607814656 |
---|---|
author | Mendes, Renata de S. Oliveira, Milena V. Padilha, Gisele A. Rocha, Nazareth N. Santos, Cintia L. Maia, Ligia A. Fernandes, Marcos V. de S. Cruz, Fernanda F. Olsen, Priscilla C. Capelozzi, Vera L. de Abreu, Marcelo Gama Pelosi, Paolo Rocco, Patricia R. M. Silva, Pedro L. |
author_facet | Mendes, Renata de S. Oliveira, Milena V. Padilha, Gisele A. Rocha, Nazareth N. Santos, Cintia L. Maia, Ligia A. Fernandes, Marcos V. de S. Cruz, Fernanda F. Olsen, Priscilla C. Capelozzi, Vera L. de Abreu, Marcelo Gama Pelosi, Paolo Rocco, Patricia R. M. Silva, Pedro L. |
author_sort | Mendes, Renata de S. |
collection | PubMed |
description | BACKGROUND: Conflicting data have reported beneficial effects of crystalloids, hyper-oncotic albumin (20%ALB), and iso-oncotic albumin (5%ALB) in critically ill patients. Although hyper-oncotic albumin may minimize lung injury, recent studies have shown that human albumin may lead to kidney damage proportional to albumin concentration. In this context, we compared the effects of Ringer’s lactate (RL), 20%ALB, and 5%ALB, all titrated according to similar hemodynamic goals, on pulmonary function, lung and kidney histology, and molecular biology in experimental acute lung injury (ALI). METHODS: Male Wistar rats received Escherichia coli lipopolysaccharide intratracheally (n = 24) to induce ALI. After 24 h, animals were anesthetized and randomly assigned to receive RL, 20%ALB, or 5%ALB (n = 6/group) to maintain hemodynamic stability (distensibility index of inferior vena cava < 25%, mean arterial pressure > 65 mmHg). Rats were then mechanically ventilated for 6 h. Six animals, which received neither ventilation nor fluids (NV), were used for molecular biology analyses. RESULTS: The total fluid volume infused was higher in RL compared to 5%ALB and 20%ALB (median [interquartile range], 10.8[8.2–33.2] vs. 4.8[3.6–7.7] and 4.3[3.9–6.6] mL, respectively; p = 0.02 and p = 0.003). B-line counts on lung ultrasound (p < 0.0001 and p = 0.0002) and serum lactate levels (p = 0.01 and p = 0.01) were higher in RL than 5%ALB and 20%ALB. Diffuse alveolar damage score was lower in 5%ALB (10.5[8.5–12]) and 20%ALB (10.5[8.5–14]) than RL (16.5[12.5–20.5]) (p < 0.05 and p = 0.03, respectively), while acute kidney injury score was lower in 5%ALB (9.5[6.5–10]) than 20%ALB (18[15–28.5], p = 0.0006) and RL (16 [15–19], p = 0.04). In lung tissue, mRNA expression of interleukin (IL)-6 was higher in RL (59.1[10.4–129.3]) than in 5%ALB (27.0[7.8–49.7], p = 0.04) or 20%ALB (3.7[7.8–49.7], p = 0.03), and IL-6 protein levels were higher in RL than 5%ALB and 20%ALB (p = 0.026 and p = 0.021, respectively). In kidney tissue, mRNA expression and protein levels of kidney injury molecule (KIM)-1 were lower in 5%ALB than RL and 20%ALB, while nephronectin expression increased (p = 0.01 and p = 0.01), respectively. CONCLUSIONS: In a rat model of ALI, both iso-oncotic and hyper-oncotic albumin solutions were associated with less lung injury compared to Ringer’s lactate. However, hyper-oncotic albumin resulted in greater kidney damage than iso-oncotic albumin. This experimental study is a step towards future clinical designs. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12931-019-1115-x) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-6636113 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-66361132019-07-25 Effects of crystalloid, hyper-oncotic albumin, and iso-oncotic albumin on lung and kidney damage in experimental acute lung injury Mendes, Renata de S. Oliveira, Milena V. Padilha, Gisele A. Rocha, Nazareth N. Santos, Cintia L. Maia, Ligia A. Fernandes, Marcos V. de S. Cruz, Fernanda F. Olsen, Priscilla C. Capelozzi, Vera L. de Abreu, Marcelo Gama Pelosi, Paolo Rocco, Patricia R. M. Silva, Pedro L. Respir Res Research BACKGROUND: Conflicting data have reported beneficial effects of crystalloids, hyper-oncotic albumin (20%ALB), and iso-oncotic albumin (5%ALB) in critically ill patients. Although hyper-oncotic albumin may minimize lung injury, recent studies have shown that human albumin may lead to kidney damage proportional to albumin concentration. In this context, we compared the effects of Ringer’s lactate (RL), 20%ALB, and 5%ALB, all titrated according to similar hemodynamic goals, on pulmonary function, lung and kidney histology, and molecular biology in experimental acute lung injury (ALI). METHODS: Male Wistar rats received Escherichia coli lipopolysaccharide intratracheally (n = 24) to induce ALI. After 24 h, animals were anesthetized and randomly assigned to receive RL, 20%ALB, or 5%ALB (n = 6/group) to maintain hemodynamic stability (distensibility index of inferior vena cava < 25%, mean arterial pressure > 65 mmHg). Rats were then mechanically ventilated for 6 h. Six animals, which received neither ventilation nor fluids (NV), were used for molecular biology analyses. RESULTS: The total fluid volume infused was higher in RL compared to 5%ALB and 20%ALB (median [interquartile range], 10.8[8.2–33.2] vs. 4.8[3.6–7.7] and 4.3[3.9–6.6] mL, respectively; p = 0.02 and p = 0.003). B-line counts on lung ultrasound (p < 0.0001 and p = 0.0002) and serum lactate levels (p = 0.01 and p = 0.01) were higher in RL than 5%ALB and 20%ALB. Diffuse alveolar damage score was lower in 5%ALB (10.5[8.5–12]) and 20%ALB (10.5[8.5–14]) than RL (16.5[12.5–20.5]) (p < 0.05 and p = 0.03, respectively), while acute kidney injury score was lower in 5%ALB (9.5[6.5–10]) than 20%ALB (18[15–28.5], p = 0.0006) and RL (16 [15–19], p = 0.04). In lung tissue, mRNA expression of interleukin (IL)-6 was higher in RL (59.1[10.4–129.3]) than in 5%ALB (27.0[7.8–49.7], p = 0.04) or 20%ALB (3.7[7.8–49.7], p = 0.03), and IL-6 protein levels were higher in RL than 5%ALB and 20%ALB (p = 0.026 and p = 0.021, respectively). In kidney tissue, mRNA expression and protein levels of kidney injury molecule (KIM)-1 were lower in 5%ALB than RL and 20%ALB, while nephronectin expression increased (p = 0.01 and p = 0.01), respectively. CONCLUSIONS: In a rat model of ALI, both iso-oncotic and hyper-oncotic albumin solutions were associated with less lung injury compared to Ringer’s lactate. However, hyper-oncotic albumin resulted in greater kidney damage than iso-oncotic albumin. This experimental study is a step towards future clinical designs. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12931-019-1115-x) contains supplementary material, which is available to authorized users. BioMed Central 2019-07-16 2019 /pmc/articles/PMC6636113/ /pubmed/31311539 http://dx.doi.org/10.1186/s12931-019-1115-x Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Mendes, Renata de S. Oliveira, Milena V. Padilha, Gisele A. Rocha, Nazareth N. Santos, Cintia L. Maia, Ligia A. Fernandes, Marcos V. de S. Cruz, Fernanda F. Olsen, Priscilla C. Capelozzi, Vera L. de Abreu, Marcelo Gama Pelosi, Paolo Rocco, Patricia R. M. Silva, Pedro L. Effects of crystalloid, hyper-oncotic albumin, and iso-oncotic albumin on lung and kidney damage in experimental acute lung injury |
title | Effects of crystalloid, hyper-oncotic albumin, and iso-oncotic albumin on lung and kidney damage in experimental acute lung injury |
title_full | Effects of crystalloid, hyper-oncotic albumin, and iso-oncotic albumin on lung and kidney damage in experimental acute lung injury |
title_fullStr | Effects of crystalloid, hyper-oncotic albumin, and iso-oncotic albumin on lung and kidney damage in experimental acute lung injury |
title_full_unstemmed | Effects of crystalloid, hyper-oncotic albumin, and iso-oncotic albumin on lung and kidney damage in experimental acute lung injury |
title_short | Effects of crystalloid, hyper-oncotic albumin, and iso-oncotic albumin on lung and kidney damage in experimental acute lung injury |
title_sort | effects of crystalloid, hyper-oncotic albumin, and iso-oncotic albumin on lung and kidney damage in experimental acute lung injury |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6636113/ https://www.ncbi.nlm.nih.gov/pubmed/31311539 http://dx.doi.org/10.1186/s12931-019-1115-x |
work_keys_str_mv | AT mendesrenatades effectsofcrystalloidhyperoncoticalbuminandisooncoticalbuminonlungandkidneydamageinexperimentalacutelunginjury AT oliveiramilenav effectsofcrystalloidhyperoncoticalbuminandisooncoticalbuminonlungandkidneydamageinexperimentalacutelunginjury AT padilhagiselea effectsofcrystalloidhyperoncoticalbuminandisooncoticalbuminonlungandkidneydamageinexperimentalacutelunginjury AT rochanazarethn effectsofcrystalloidhyperoncoticalbuminandisooncoticalbuminonlungandkidneydamageinexperimentalacutelunginjury AT santoscintial effectsofcrystalloidhyperoncoticalbuminandisooncoticalbuminonlungandkidneydamageinexperimentalacutelunginjury AT maialigiaa effectsofcrystalloidhyperoncoticalbuminandisooncoticalbuminonlungandkidneydamageinexperimentalacutelunginjury AT fernandesmarcosvdes effectsofcrystalloidhyperoncoticalbuminandisooncoticalbuminonlungandkidneydamageinexperimentalacutelunginjury AT cruzfernandaf effectsofcrystalloidhyperoncoticalbuminandisooncoticalbuminonlungandkidneydamageinexperimentalacutelunginjury AT olsenpriscillac effectsofcrystalloidhyperoncoticalbuminandisooncoticalbuminonlungandkidneydamageinexperimentalacutelunginjury AT capelozziveral effectsofcrystalloidhyperoncoticalbuminandisooncoticalbuminonlungandkidneydamageinexperimentalacutelunginjury AT deabreumarcelogama effectsofcrystalloidhyperoncoticalbuminandisooncoticalbuminonlungandkidneydamageinexperimentalacutelunginjury AT pelosipaolo effectsofcrystalloidhyperoncoticalbuminandisooncoticalbuminonlungandkidneydamageinexperimentalacutelunginjury AT roccopatriciarm effectsofcrystalloidhyperoncoticalbuminandisooncoticalbuminonlungandkidneydamageinexperimentalacutelunginjury AT silvapedrol effectsofcrystalloidhyperoncoticalbuminandisooncoticalbuminonlungandkidneydamageinexperimentalacutelunginjury |